Patents by Inventor Bart Merkus

Bart Merkus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nasal compositions stimulating ciliary activity
    Patent number: 10751343
    Abstract: Nasal compositions, comprising an aqueous solution containing caffeine and/or theobromine in a total concentration of up to about 0.5 percent (w/v) and an aqueous carrier having a pH of about 6-8 and comprising physiologically acceptable salts of sodium, potassium and calcium. The nasal composition when used as a nasal spray or as nasal drops or irrigation fluid is able to clean the nasal passages and to stimulate nasal mucociliary clearance and, in contrast to nasal decongestants, may be used on a daily-basis for a period longer than 5 days.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: August 25, 2020
    Assignees: Innotesto BVBA, Veramed BV
    Inventors: Franciscus Wilhelmus Henricus Maria Merkus, Bart Merkus
  • NASAL COMPOSITIONS STIMULATING CILIARY ACTIVITY
    Publication number: 20200085831
    Abstract: Nasal compositions, comprising an aqueous solution containing caffeine and/or theobromine in a total concentration of up to about 0.5 percent (w/v) and an aqueous carrier having a pH of about 6-8 and comprising physiologically acceptable salts of sodium, potassium and calcium. The nasal composition when used as a nasal spray or as nasal drops or irrigation fluid is able to clean the nasal passages and to stimulate nasal mucociliary clearance and, in contrast to nasal decongestants, may be used on a daily-basis for a period longer than 5 days.
    Type: Application
    Filed: November 21, 2019
    Publication date: March 19, 2020
    Inventors: Franciscus Wilhelmus Henricus Maria Merkus, Bart Merkus
  • NASAL COMPOSITIONS STIMULATING CILIARY ACTIVITY
    Publication number: 20160271135
    Abstract: Nasal compositions, comprising an aqueous solution containing caffeine and/or theobromine in a total concentration of up to about 0.5% (w/v) and an aqueous carrier having a pH of about 6-8 and comprising physiologically acceptable salts of sodium, potassium and calcium. The nasal composition when used as a nasal spray or as nasal drops or irrigation fluid is able to clean the nasal passages and to stimulate nasal mucociliary clearance and, in contrast to nasal decongestants, may be used on a daily-basis for a period longer than 5 days.
    Type: Application
    Filed: October 30, 2014
    Publication date: September 22, 2016
    Applicants: INNOTESTO BVBA, Veramed B.V.
    Inventors: Franciscus Wilhelmus Henricus Maria Merkus, Bart Merkus